Symbiox Investment & Trading Co Ltd (BOM:539278)
India · Delayed Price · Currency is INR 1.700
-0.030 (-1.73%)
At close: Jun 1, 2026
BOM:539278 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 16.03 | 27.64 | 38.98 | 39.82 | 18.3 |
Other Revenue | - | 0 | 0.01 | 0.01 | 0 |
| 16.03 | 27.64 | 38.99 | 39.83 | 18.31 | |
Revenue Growth (YoY) | -42.01% | -29.11% | -2.12% | 117.60% | -40.71% |
Cost of Revenue | 9.99 | 21.14 | 34.75 | 32.32 | 10.95 |
Gross Profit | 6.04 | 6.5 | 4.24 | 7.52 | 7.36 |
Selling, General & Admin | 2.05 | 1.88 | 2.24 | 2.5 | 2.14 |
Other Operating Expenses | 1.93 | 2.06 | 1.81 | 3.01 | 3.46 |
Operating Expenses | 4 | 3.94 | 4.05 | 5.51 | 5.6 |
Operating Income | 2.04 | 2.56 | 0.19 | 2 | 1.76 |
Interest Expense | - | -0 | -0 | -0 | - |
Interest & Investment Income | - | 0.04 | 0.01 | 0.09 | - |
Other Non Operating Income (Expenses) | 0.02 | -0 | -0.01 | -0 | -0 |
EBT Excluding Unusual Items | 2.06 | 2.59 | 0.19 | 2.09 | 1.75 |
Gain (Loss) on Sale of Assets | - | - | 2.28 | 0.07 | 0.12 |
Pretax Income | 2.06 | 2.59 | 2.48 | 2.15 | 1.88 |
Income Tax Expense | 0.54 | 0.67 | 0.39 | 0.56 | 0.49 |
Net Income | 1.52 | 1.92 | 2.08 | 1.59 | 1.39 |
Net Income to Common | 1.52 | 1.92 | 2.08 | 1.59 | 1.39 |
Net Income Growth | -20.63% | -7.86% | 30.88% | 14.57% | 100.12% |
Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 |
Shares Outstanding (Diluted) | 31 | 31 | 31 | 31 | 31 |
Shares Change (YoY) | -0.54% | 1.20% | -0.36% | -0.29% | - |
EPS (Basic) | 0.05 | 0.06 | 0.07 | 0.05 | 0.04 |
EPS (Diluted) | 0.05 | 0.06 | 0.07 | 0.05 | 0.04 |
EPS Growth | -20.20% | -8.96% | 31.36% | 14.91% | 100.13% |
Free Cash Flow | 27.26 | 35.83 | -30.74 | -44.72 | -3.51 |
Free Cash Flow Per Share | 0.87 | 1.14 | -0.99 | -1.43 | -0.11 |
Gross Margin | 37.66% | 23.50% | 10.87% | 18.87% | 40.20% |
Operating Margin | 12.70% | 9.26% | 0.49% | 5.02% | 9.59% |
Profit Margin | 9.50% | 6.94% | 5.34% | 4.00% | 7.59% |
Free Cash Flow Margin | 170.06% | 129.62% | -78.84% | -112.28% | -19.18% |
EBITDA | 2.06 | 2.59 | 0.21 | - | - |
EBITDA Margin | 12.88% | 9.36% | 0.54% | - | - |
D&A For EBITDA | 0.03 | 0.03 | 0.02 | - | - |
EBIT | 2.04 | 2.56 | 0.19 | 2 | 1.76 |
EBIT Margin | 12.70% | 9.26% | 0.49% | 5.02% | 9.59% |
Effective Tax Rate | 26.00% | 26.00% | 15.86% | 26.16% | 26.00% |
Revenue as Reported | 16.05 | 27.68 | 41.28 | 39.99 | 18.43 |
Advertising Expenses | - | 0.11 | 0.14 | 0.43 | 0.37 |